BOIMMG

1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

generic_lipid

BOIMMG ID - 268621

Name - 1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

SMILES - CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@H]1O

InChIKey - OXVIQSLJPDSXGU-ITIMFUHCSA-G

Formula - C63H97O22P4

Annotated - ✔

SWISS LIPIDS id - SLM:000440823

+Structural Parent

+Precursors

+Components

Lipid name	Formula	BOIMMG ID	Listed
1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4,5-bisphosphate	C63H98O19P3	291872	✔
1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4-phosphate	C63H99O16P2	281228	✔
1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol	C63H100O13P	18484	✔
CDP-1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycerol	C66H101N3O15P2	568064	✔
1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3-phosphate	C63H99O16P2	269854	✔
1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphate	C57H89O8P	20902	✔
Acyl-ACP ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate)	C22H31OSR1	749642	✗
1-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycero-3-phosphate	C35H59O7P	6823	✔
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA	C43H62N7O17P3S	383	✔
Acyl-ACP ((17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoate)	C32H53OSR1	749623	✗
Acyl-Phosphates ((17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoate)	C32H55O5P	736130	✗